Add to ORKGPirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine Conclusions: Pirfenidone attenuated the fibrocyte pool size in bleomycin-treated mouse lungs via attenuation of CCL2 and Inomata et al. Respiratory Research 2014, 15:1
Although immune checkpoint and targeted therapies offer remarkable benefits for lung cancer treatmen...
International audienceBackground: Pulmonary hypertension (PH) is a common complication of idiopathic...
Allogeneic hematopoietic stem cell transplantation is hampered by chronic graft-versus-host disease ...
Abstract Background Oxidative stress is one of the important factors involved in the pathogenesis of...
Background: Pirfenidone, a pleiotropic anti-fibrotic treatment, has been shown to slow down disease ...
Pirfenidone is an orally active small molecule that has recently been evaluated in large clinical tr...
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Repetitive inj...
The antifibrotic potential of pirfenidone (5-methyl-1-phenyl-2-[1H]- pyridone) was examined in a sin...
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Repetitive inj...
Abstract Background Pirfenidone (PFD) is an anti-fibrotic agent used to treat idiopathic pulmonary f...
BACKGROUND Fibrosis as a common problem in patients with Crohn's disease is a result of an imbalance...
BACKGROUND: Pulmonary fibrosis (PF) is a group of devastating and largely irreversible diseases. Pho...
Abstract Background Pirfenidone, a pleiotropic anti-fibrotic treatment, has been shown to slow down ...
Context: Previous studies have reported that caveolin-1 (Cav-1) is associated with lung fibrosis. Ho...
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Repeti...
Although immune checkpoint and targeted therapies offer remarkable benefits for lung cancer treatmen...
International audienceBackground: Pulmonary hypertension (PH) is a common complication of idiopathic...
Allogeneic hematopoietic stem cell transplantation is hampered by chronic graft-versus-host disease ...
Abstract Background Oxidative stress is one of the important factors involved in the pathogenesis of...
Background: Pirfenidone, a pleiotropic anti-fibrotic treatment, has been shown to slow down disease ...
Pirfenidone is an orally active small molecule that has recently been evaluated in large clinical tr...
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Repetitive inj...
The antifibrotic potential of pirfenidone (5-methyl-1-phenyl-2-[1H]- pyridone) was examined in a sin...
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Repetitive inj...
Abstract Background Pirfenidone (PFD) is an anti-fibrotic agent used to treat idiopathic pulmonary f...
BACKGROUND Fibrosis as a common problem in patients with Crohn's disease is a result of an imbalance...
BACKGROUND: Pulmonary fibrosis (PF) is a group of devastating and largely irreversible diseases. Pho...
Abstract Background Pirfenidone, a pleiotropic anti-fibrotic treatment, has been shown to slow down ...
Context: Previous studies have reported that caveolin-1 (Cav-1) is associated with lung fibrosis. Ho...
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Repeti...
Although immune checkpoint and targeted therapies offer remarkable benefits for lung cancer treatmen...
International audienceBackground: Pulmonary hypertension (PH) is a common complication of idiopathic...
Allogeneic hematopoietic stem cell transplantation is hampered by chronic graft-versus-host disease ...